Home > Insider Trading > Filing (0001449374-11-000083)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
764579	Cas Medical Systems Inc	CASM	Surgical & Medical Instruments & Apparatus (3841)	061123096

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310306	M Thomas Patton	C/O Cas Medical Systems, Inc. 44 East Industrial Road Branford CT 06405	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-18	18,900	$1.80	493,019	No	4	P	Direct
Common Stock	Acquisiton	2011-11-21	14,426	$1.75	507,445	No	4	P	Direct
Common Stock	Acquisiton	2011-11-21	12,500	$1.75	32,500	No	4	P	Indirect	Reporting Person has dispositive power over the securities, which are held in a relative's IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	Reporting Person has dispositive power over the securities, which are held in a relative's IRA

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.76 to $1.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7448 to $1.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3).